Search

everythinglearnresearchcommunity

for

Search:↓

Tinea capitis is increasingly common in elderly women and requires accurate diagnosis with fungal cultures for effective treatment.

More precise, personalized therapies are needed for autoimmune diseases.

Secondary syphilis in Cali, Colombia, shows high Treponema pallidum presence and challenges in early diagnosis, needing better public health strategies.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.

Excessive selenium in supplements can cause hair loss and nail issues.

Laser-assisted drug delivery is generally safe with mostly mild side effects.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

Pili torti is a rare condition where hair is twisted and breaks easily, often linked to genetic disorders or other health issues.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

Nanomaterials can improve hair care products and treatments, including hair loss and alopecia, by enhancing stability and safety, and allowing controlled release of compounds, but their safety in cosmetics needs more understanding.

COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Microneedling radiofrequency improves skin texture and tone by stimulating collagen and elastin.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

The skin microbiome is crucial for skin health and new treatments like probiotics can improve skin conditions.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

Dupilumab and COVID-19 can worsen or trigger psoriasis.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.